PerkinElmer Inc (NYSE:PKI)
| 137.33 Delayed Data As of Dec 06 |  +0.04 / +0.03%Today’s Change | 113.46 Today|||52-Week Range 203.16 | -31.70% Year-to-Date |
Latest PKI News | Press Releases
| Here's Why You Should Retain PerkinElmer (PKI) Stock Now Nov 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 137.29 |
| Today’s open | 137.80 |
| Day’s range | 135.89 - 139.43 |
| Volume | 632,173 |
| Average volume (3 months) | 820,404 |
| Market cap | $17.6B |
Data as of 4:00pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | +24.39% |
| Earnings growth (this year) | -30.84% |
| Earnings growth (next 5 years) | -10.95% |
| Revenue growth (last year) | +33.95% |
| P/E ratio | 26.8 |
| Price/Sales | 4.63 |
| Price/Book | 2.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | +0.01 | +0.00% |
| QGENQiagen NV | -0.02 | -0.04% |
| BIOBio Rad Laboratories... | +0.53 | +0.13% |
| BRKRBruker Corp | -0.59 | -0.88% |
Data as of 4:00pm ET, 12/06/2022
Financials
| Next reporting date | January 31, 2023 |
| EPS forecast (this quarter) | $1.65 |
| Annual revenue (last year) | $5.1B |
| Annual profit (last year) | $943.3M |
| Net profit margin | 18.62% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
